Next Quarterly Earnings
Thursday, July 30, 2026
CW 31
Pre-Market
In 25 days
Insmed Incorporated is a global US-based biopharmaceutical company dedicated to developing and commercializing innovative medicines for patients with rare and severe diseases. Its portfolio features treatments for specific lung diseases and neuromuscular disorders, addressing significant unmet medical needs.